Hypoalbuminaemia after Bedinvetmab (Librela) in dogs

The FDA has received 154 reports of hypoalbuminaemia in dogs after Bedinvetmab. That is 0.8% of all reports for this medicine, compared with 0.6% across reports for all dog medicines.

154Reports

79%Marked serious

5.2%Recovered

35%Died or euthanised

16 daysTypical onset

How soon it started

Same day

25 18%

1–2 days

14 10%

3–7 days

16 12%

1–4 weeks

38 27%

Over a month

46 33%

How the animals did

Recovered

8 5.2%

Still unwell when reported

84 55%

Died

11 7.1%

Euthanised

43 28%

Not known

8 5.2%

Problems reported at the same time

67 44%

57 37%

56 36%

54 35%

52 34%

46 30%

43 28%

38 25%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Bedinvetmab reduces osteoarthritis pain in dogs (monthly injection).

Products with this ingredient include Librela. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Bedinvetmab cause hypoalbuminaemia in dogs?: 154 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 16 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hypoalbuminaemia with similar medicines

Hypoalbuminaemia after Lokivetmab (Cytopoint) 94 reports · 1.4% of its reports

All reported side effects of Bedinvetmab in dogs · Medicines most reported with hypoalbuminaemia